| scholarly article | Q13442814 |
| P2093 | author name string | Susan K Schultz | |
| Leigh J Beglinger | |||
| Natalie L Denburg | |||
| Torricia H Yamada | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Attention and executive deficits in Alzheimer's disease. A critical review | Q33545617 | ||
| Cognitive function after systemic therapy for breast cancer | Q34276123 | ||
| Cognitive effects of standard-dose chemotherapy in patients with cancer | Q34478294 | ||
| Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature | Q35635738 | ||
| Cognitive function in breast cancer patients receiving adjuvant chemotherapy. | Q51079423 | ||
| Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. | Q51986288 | ||
| Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. | Q52015136 | ||
| Computerized assessment in neuropsychiatry using CANTAB: discussion paper | Q68205413 | ||
| P433 | issue | 1 | |
| P921 | main subject | chemotherapy | Q974135 |
| neuropsychology | Q3872 | ||
| breast cancer | Q128581 | ||
| P304 | page(s) | 48-54 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Journal of Neuropsychiatry and Clinical Neurosciences | Q15753636 |
| P1476 | title | Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy | |
| P478 | volume | 22 |
| Q64062978 | 'A new normal with chemobrain': Experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors |
| Q35161191 | A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer. |
| Q38000038 | An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors |
| Q35059702 | An update on cancer- and chemotherapy-related cognitive dysfunction: current status |
| Q58597998 | Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review |
| Q36543428 | Associations Between Physical Fitness Indices and Working Memory in Breast Cancer Survivors and Age-Matched Controls |
| Q37211338 | Brain vulnerability to chemotherapy toxicities |
| Q37015812 | Cancer 'survivor-care': II. Disruption of prefrontal brain activation top-down control of working memory capacity as possible mechanism for chemo-fog/brain (chemotherapy-associated cognitive impairment). |
| Q26853289 | Cancer- and cancer treatment-associated cognitive change: an update on the state of the science |
| Q37997653 | Chemotherapy-related cognitive dysfunction |
| Q33926534 | Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits. |
| Q38933679 | Cognition and Cognitive Impairment in Older Adults with Cancer |
| Q47356469 | Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: A longitudinal cohort study. |
| Q37431101 | Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? |
| Q34031141 | Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors |
| Q36331164 | Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions |
| Q37067793 | Cognitive function in cancer survivors: analysis of the 1999-2002 National Health and Nutrition Examination Survey |
| Q37576583 | Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907. |
| Q33729085 | Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? |
| Q24594173 | Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors |
| Q35008290 | Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients |
| Q35133442 | Frontal hypometabolism in elderly breast cancer survivors determined by [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study |
| Q48229486 | Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy |
| Q36867082 | Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study |
| Q90179391 | Hippocampus-Related Cognitive and Affective Impairments in Patients With Breast Cancer-A Systematic Review |
| Q57390770 | Impact de la chimiothérapie adjuvante sur les fonctions cognitives dans le cancer du sein: revue de la littérature |
| Q36027020 | Long-term subjective cognitive functioning following adjuvant systemic treatment: 7-9 years follow-up of a nationwide cohort of women treated for primary breast cancer |
| Q30489606 | Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). |
| Q34395112 | Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. |
| Q35935819 | Moderate Physical Activity Mediates the Association between White Matter Lesion Volume and Memory Recall in Breast Cancer Survivors |
| Q35371156 | Objectively measured physical activity and cognitive functioning in breast cancer survivors |
| Q41682625 | Special Issues in Older Women with Breast Cancer |
| Q39212333 | Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature. |
| Q38629963 | The Role of Age in Neurocognitive Functioning among Adult Allogeneic Hematopoietic Cell Transplant Recipients. |
| Q36778320 | The impact of cancer therapy on cognition in the elderly |
| Q45958149 | Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial. |
| Q41663182 | Very Late Treatment-Related Alterations in Brain Function of Breast Cancer Survivors |
Search more.